Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Institut Català d'Oncologia Hospitalet

2 abstracts

Abstract
BELLWAVE-003: A phase 2 dose escalation, confirmation, and cohort expansion study of nemtabrutinib in hematologic malignancies.
Org: Hospital Paulistano and Instituto Américas, Tom Baker Cancer Centre, Ankara University School of Medicine, MSC National Research Institute of Oncology, Kraków, Poland, Institut Català d'Oncologia Hospitalet,
Abstract
waveLINE-007: Phase 2 study of zilovertamab vedotin (ZV) in combination with cyclophosphamide, doxorubicin, and prednisone plus rituximab (R-CHP) in previously untreated diffuse large B-cell lymphoma (DLBCL).
Org: Hadassah Medical Center, Ankara University School of Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, Institut Català d'Oncologia Hospitalet, Samsung Medical Center,